REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad de Citologia y Patologia I.P.S. S. A. S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Unidad de Citologia y Patologia I.P.S. S. A. S. Profile Updated: May 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Unidad de Citologia y Patologia I.P.S. S. A. S. is based in Colombia. The head office is in Medellin. The enterprise operates in the Diagnostic Imaging Centers industry. The company was established on February 28, 2012. It currently has a total number of 1 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 45.59% in 2024. Its total assets decreased by 39.9% over the same period. The net profit margin of Unidad de Citologia y Patologia I.P.S. S. A. S. increased by 1.4% in 2024.

Headquarters
Calle 36 D Sur 27 D 166 Int 151
Medellin; Antioquia;

Contact Details: Purchase the Unidad de Citologia y Patologia I.P.S. S. A. S. report to view the information.

Basic Information
Total Employees:
Purchase the Unidad de Citologia y Patologia I.P.S. S. A. S. report to view the information.
Financial Auditors:
Purchase the Unidad de Citologia y Patologia I.P.S. S. A. S. report to view the information.
Incorporation Date:
February 28, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad de Citologia y Patologia I.P.S. S. A. S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-45.59%
Total operating revenue
-45.59%
Operating profit (EBIT)
-86.87%
Net Profit (Loss) for the Period
46.51%
Total assets
-39.9%
Total equity
-36.67%
Operating Profit Margin (ROS)
-6.98%
Net Profit Margin
1.4%
Return on Equity (ROE)
1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?